drugset / Trial / NCT02460107
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in patients with diabetic peripheral polyneuropathy.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-11-30
- Completion
- 2016-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 50 iu | — |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 100 iu | — |